Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.7K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

8.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.3K
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

75
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
75
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

43
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
43
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

4.8K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.8K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

38
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
38

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Deep learning models for rapid discrimination of high-grade gliomas from solitary brain metastases using multi-plane T1-weighted contrast-enhanced (T1CE) images.

Quantitative imaging in medicine and surgery·2024
Same author

Enhancing generalizability and performance in drug-target interaction identification by integrating pharmacophore and pre-trained models.

Bioinformatics (Oxford, England)·2024
Same author

ROCK2 disturbs MKP1 expression to promote invasion and metastasis in hepatocellular carcinoma.

American journal of cancer research·2020
Same author

Transumbilical multiport laparoscopic nephrectomy with specimen extraction through the vagina.

Urologia internationalis·2014
Same author

Suprapubic-assisted laparoendoscopic single-site surgery (LESS) in urology: our experience.

BJU international·2013
Same author

Pure transvaginal natural orifice translumenal endoscopic surgery for renal cyst decortication: report of initial five cases.

International journal of urology : official journal of the Japanese Urological Association·2013
Same journal

Mapping Evolution of Molecules across Biochemistry with Assembly Theory.

Journal of chemical information and modeling·2026
Same journal

Structural Proteomics-Based Deciphering of Hydrophobic Packing Fingerprints Informing Protein Thermostability in TIM Barrels.

Journal of chemical information and modeling·2026
Same journal

Bridging between Structure-Based and Data-Driven Affinity Prediction.

Journal of chemical information and modeling·2026
Same journal

Reinforcement Learning-Driven Multiproperty Optimization in Molecular Design Using Multicontext Transcriptome Data.

Journal of chemical information and modeling·2026
Same journal

EnsembleCycPerm: Interpretable Modeling of Cyclic Peptide Permeability through Solvent-Dependent Conformational Ensembles.

Journal of chemical information and modeling·2026
Same journal

Resolving Conformational Preferences of Monosaccharides from <sup>1</sup>H and <sup>13</sup>C NMR Chemical Shifts Using an Integrated MD and QM Approach.

Journal of chemical information and modeling·2026
查看所有相关文章

相关实验视频

Updated: Jun 4, 2025

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.7K

康尼特:一种多视图深度学习模型,用于预测药物组合副作用.

Zuolong Zhang1, Fang Liu2, Xiaonan Shang2

  • 1School of Software, Henan University, Kaifeng 475000, Henan, China.

Journal of chemical information and modeling
|January 3, 2025
PubMed
概括
此摘要是机器生成的。

预测药物组合副作用至关重要. 新型深度学习模型ComNet通过整合多视图药物特征和多尺度图形结构来提高准确性,优于现有方法,特别是在新奇的场景中.

更多相关视频

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.4K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K

相关实验视频

Last Updated: Jun 4, 2025

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.7K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.4K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K

科学领域:

  • 药理学和化学信息学
  • 人工智能在药物发现中的作用

背景情况:

  • 组合疗法越来越普遍,需要准确预测药物不良反应.
  • 现有的用于预测药物副作用的计算模型在利用多视图药物信息和捕获复杂结构相互作用方面存在局限性.
  • 整合不同的分子特征和多尺度图形信息仍然是药物副作用预测的挑战.

研究的目的:

  • 开发一个深度学习模型,ComNet,通过整合多视图药物特征来更好地预测药物不良副作用.
  • 通过结合多种分子表示和多尺度图形结构来解决现有模型的局限性.
  • 提高计算药物安全评估的准确性和稳定性.

主要方法:

  • 提出了ComNet,这是一个深度学习框架,集成了多视图特征提取模块 (分子指纹,SMILES语义,3D构造).
  • 实施了多级子图的融合机制,以捕获本地和全球药物图结构.
  • 利用基于注意力的多视图功能融合机制进行适应性重量调整.

主要成果:

  • 在预测药物组合副作用方面,ComNet在各种复杂场景 (包括冷启动情况) 中表现优于现有方法.
  • 废弃性研究证实了ComNet的每个核心组件对其整体性能的重大贡献.
  • 进一步的分析揭示了ComNet的快速融合,良好的概括能力和识别关键分子亚结构的能力.

结论:

  • 康尼特有效地整合了多视图分子特征和多尺度图形结构,以准确预测药物副作用.
  • 该模型显示了药物安全性评估和临床决策中的实践应用的巨大潜力.
  • 康美网提供了一种强大而可通用的方法来应对在组合疗法中预测不良影响的挑战.